Fitabeo Therapeutics

Fitabeo Therapeutics is a clinical-stage pharmaceutical company primarily focused on developing drugs for patients with advanced incurable diseases or chronic debilitating conditions. Fitabeo's technology enables the controlled release of one or more drugs on a fast-dissolving single-layer film, with drug release durations lasting up to 12 hours. This technology has the potential to transform lives by enabling the development and commercialization of medications that reduce dosing to twice daily, replacing traditional medications and hospital-administered treatments, thereby allowing patients to live independently at home for longer periods. The company is currently developing innovative drugs aimed at alleviating chronic pain in terminally ill patients, significantly improving their quality of life.